<div><strong>Fighting for Debbie: Funding Her Personalised Life-Saving Treatment</strong>
</div>
<div><br />
</div>
<div>Dear Friends, Family, and Supporters,
</div>
<div><br />
</div>
<div>Five years ago, our beloved Debbie faced Stage 4 Hodgkin’s Lymphoma with incredible courage and won. We thought that dark chapter was behind us. Tragically, life has dealt Debbie another devastating blow completely unrelated to her past illness. At just 44 years old, Debbie has been diagnosed with a WHO Grade 4 Glioblastoma — an aggressive brain tumor.
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>Urgent Update: Our New Goal &amp; Crucial Deadline</strong>
</div>
<div>The medical facility in Germany requires the first full year of Dendritic Cell Therapy, along with the highly complex cellular logistics, to be paid in full, upfront.
</div>
<div><br />
</div>
<div>Because of this rigid protocol, we do not have months to raise these funds incrementally. We must secure her first-year clinical costs immediately to ensure her living tumor tissue can be processed.
</div>
<div>To cover her upfront medical bills abroad, past out-of-pocket structural adaptations, and immediate clinical support, we have launched a new, short-term, explicit target: <strong>Our Fundraising Goal is €120,000.</strong>
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>The Medical Reality &amp; A Ray of Hope</strong>
</div>
<div>Debbie underwent major brain surgery to remove the tumor. Her recent pathology reports outline a complex molecular diagnosis: Glioblastoma IDH Wildtype with an FGFR3::TACC3 fusion. While this is a serious and aggressive tumor, her specific genetic makeup reveals two crucial pillars of hope:
</div>
<div><br />
</div>
<ul>
<li><strong>The</strong> <strong>FGFR3::TACC3 Fusion:</strong> This rare driver alteration means her tumor has a specific molecular target that is potentially treatable with advanced, targeted therapies. Per her medical team, this specific fusion is associated with slightly longer survival rates.
</li>
<li><strong>MGMT Promoter Methylation:</strong> Her supplementary tests show her tumor is MGMT Methylated (17%). This is a highly favorable prognostic factor indicating her cancer is statistically much more responsive to standard chemotherapy agents.
</li>
</ul>
<div><br />
</div>
<div>Because <strong>the standard Irish health system has no avenues for personalised vaccines</strong>, we must look abroad to save her life. We are coordinating specialised Dendritic Cell Therapy in Cologne, Germany. Doctors will use Debbie’s own preserved tumor tissue to create a personalised vaccine designed to train her immune system to aggressively target and destroy any remaining cancer cells.
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>The Upfront Cost Breakdown</strong>
</div>
<div>To get Debbie to Germany and maintain her care at home, we face the following costs plus travel and accommodation expenses:
</div>
<div><br />
</div>
<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/102124007_1782722340197760_r.jpg" width="100%" />
<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/102124007_1782722368176380_r.jpg" width="100%" />
<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/102124007_1782722399661648_r.jpg" width="100%" />
<div><br />
</div>
<div><br />
</div>
<div><strong>Debbie’s Timeline: A Crucial Roadmap</strong>
</div>
<div>Debbie’s timeline is intense, and the windows to act are tight. Your support directly funds these exact milestones:
</div>
<div><br />
</div>
<ul>
<li><strong>21 May – 02 July 2026:</strong> Combined Radiation &amp; Oral Chemotherapy (Standard Care)
</li>
<li><strong>27 Jul 2026 – 03 Feb 2027: </strong>6-Month Intensive Chemotherapy Block + Monthly visits to Cologne for Treatment.
</li>
</ul>
<div><br />
</div>
<div>Debbie has spent her whole life standing up for others, spreading humour in dark moments, and ensuring no one faces hardship alone. Now, she needs us to stand up for her.
</div>
<div><br />
</div>
<div>Please donate if you can, share her story with your network, and keep Debbie in your thoughts. Thank you from the bottom of our hearts for helping us fight for her life.
</div>

Ciara Brennan

Cormac Sheehan

Anonymous

Clara O Neill

Jason Douglas

Uma Talluri ferrer

Nat Stevens

Roberta Carroll

Michelle Cogan

FootballPlus Iago

ANNETTE HANLEY

Aisling O’Callaghan

Christoph Winterbach

Alice Burke

Noreen Power

Shell Cogan

Michael Deegan

Help Debbie Get the Treatment That Could Save Her Life

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

be_supporter_comments_enabled_supported_funds

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Help Debbie Get the Treatment That Could Save Her Life

Still €38,947 to go. Help us build momentum.